Not Signed In -
Diclofenac Potassium |
Cataflam |
Clinical Trial: Losartan and HCTZ and Amlopidine Vs Atenolol and Amlodipine
This study is no longer recruiting patients.
|
Purpose
A study to evaluate the effects of combination losartan versus combination atenolol in patients with ambulatory systolic hypertension.
| Condition | Intervention | Phase |
|---|---|---|
| Hypertension | Drug: MK0954, losartan potassium | Phase IV |
MedlinePlus related topics: High Blood Pressure
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Antihypertensive Effects of a Fixed-Dose Combination of Losartan and Hydrochlorothiazide Plus Amlodipine Versus a Hydrochlorothiazide and Atenolol Combination Plus Amlodipine in Subjects with Ambulatory Systolic Hypertension.
Further Study Details:
Study start: February 2003
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Males or females at least 18 years of age who have ambulatory systolic hypertension.
Location Information
Canada, Quebec
Merck Frosst Canada Ltd., Kirkland, Quebec, H9H3L1, Canada
Study chairs or principal investigators
Medical Monitor, Study Director, Merck
More Information
Study ID Numbers: 2005_061
Last Updated: August 31, 2005
Record first received: August 31, 2005
ClinicalTrials.gov Identifier: NCT00140959
Health Authority: Canada: Health Canada
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: August 31, 2005
Record first received: August 31, 2005
ClinicalTrials.gov Identifier: NCT00140959
Health Authority: Canada: Health Canada
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Cataflam (Drug Digest)
- Diclofenac Potassium (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
